Diplomat Pharmacy Inc  

(Public, NYSE:DPLO)   Watch this stock  
Find more results for DPLO
17.32
+0.15 (0.87%)
Nov 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 17.05 - 17.55
52 week 12.25 - 21.99
Open 17.14
Vol / Avg. 866,538.00/730,849.00
Mkt cap 1.19B
P/E 149.72
Div/yield     -
EPS 0.12
Shares 68.87M
Beta 0.74
Inst. own 74%
Nov 15, 2017
Diplomat Pharmacy Inc Acquires Leehar Distributors LLC - Webcast
Nov 8, 2017
Diplomat Pharmacy Inc at Credit Suisse Healthcare Conference - Webcast
Nov 6, 2017
Q3 2017 Diplomat Pharmacy Inc Earnings Call - Webcast
Nov 6, 2017
Q3 2017 Diplomat Pharmacy Inc Earnings Release
Sep 13, 2017
Diplomat Pharmacy Inc at Morgan Stanley Healthcare Conference
Sep 6, 2017
Diplomat Pharmacy Inc at Wells Fargo Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 0.09% 0.57%
Operating margin 0.21% 1.07%
EBITD margin - 2.20%
Return on average assets 0.34% 2.38%
Return on average equity 0.64% 5.02%
Employees 1,737 -
CDP Score - -

Address

4100 S Saginaw St
FLINT, MI 48507-2683
United States - Map
+1-888-7204450 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Diplomat Pharmacy, Inc. (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates through specialty pharmacy services segment. The Company's primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialty infusion therapy, and various other serious and/or long-term conditions. The Company provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups, hospitals and health systems. The Company offers various services, such as specialty drug dispensing, retail specialty services, hospital and health system services, and hub services. The Company's patient care system is used to coordinate and track patient adherence and safety.

Officers and directors

Joel Saban President
Age: 50
Bio & Compensation  - Reuters
Atul Kavthekar Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Robyn Peters Executive Vice President of Sales and Payor Strategies
Bio & Compensation  - Reuters
Gary Rice Executive Vice President - Operations
Age: 59
Bio & Compensation  - Reuters
Philip R. Hagerman Chairman of the Board, Chief Executive Officer, Co-Founder
Age: 64
Bio & Compensation  - Reuters
Benjamin Wolin Lead Independent Director
Age: 42
Bio & Compensation  - Reuters
Regina M. Benjamin M.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
David C. Dreyer CPA Independent Director
Age: 60
Bio & Compensation  - Reuters
Kenneth O. Klepper Independent Director
Age: 63
Bio & Compensation  - Reuters
Shawn Cline Tomasello Independent Director
Age: 58
Bio & Compensation  - Reuters